Vol. January
166,
No. 30,
2, 1990
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
Pages
1990
Epidermal Growth Induce Differential
615-621
Factor and Transforming Growth Factor-alpha Processing of the Epidermal Growth Factor Receptor Stuart
J. Decker
Rockefeller University 1230 York Ave. New York. NY 10021 Received
December
7, 1989
The capacity of epidermal growth factor (EGF) or transforming SUMMARY: growth factor-alpha (TGF-alpha) to induce internalization and degradation of the EGF receptor was compared in NIH-3T3 cells expressing the human EGF receptor. This study was initiated following the observation that TGF-alpha was much less efficient relative to EGF in generating a Mr=125,000 aminoterminally truncated degradation product from the mature EGF receptor (EGFdependent generation of this degradation product is described in S.J. Decker, J. Biol. Chem., 264:17641-17644). Pulse-chase experiments revealed that EGF generally stimulated EGF receptor degradation to a greater extent than TGFalpha. Both ligands induced EGF receptor internalization to similar degrees. However, recovery of [1251]-EGF binding following incubation with EGF or TGF-alpha was much faster for TGF-alpha treated cells. Recovery of [1251]-EGF treatment did not appear to require protein binding after TGF-alpha Tyrosine phosphorylation of EGF receptor from cells treated with synthesis. TGF-alpha decreased more rapidly following removal of TGF-alpha compared to cells treated similarly with EGF. These data suggest that EGF routes the EGF receptor directly to a degradative pathway, whereas TGF-alpho allows receptor recylcing prior to degradation, and that tyrosine phosphorylation could play a role in this differential receptor processing. 0 1990 Academic Press, Inc.
Transforming sequence to bind
similarity
with
to and activate
transmembrane
receptor
kinase
and
Despite reported
more potent induction prostacyclin
can result (5,6),
growth
factor (1).
(2,3,4). in activation
the biological
activity
production
(q), (12).
megacolony
TGF-alpha
receptor
are believed from
tyrosine
and c-myc
larger
of these
ligands specific
(7.8)
(9.10). of instances have been has been shown to be
is more effective of wound
stimulation formation
and both
of either
a number of TGF-alpha
promotion
significant
are processed
of EGF
division
characteristics,
than that of EGF.
Both
of c-for
of cell
shares
(EGF)
Binding
common
of angiogenesis
and in inducing
(TGF-ufphu)
stimulation
stimulation
these
in which
epidermal precursors
activity
transcription,
factor-alpha
the EGF receptor
protein
to the EGF protein
growth
of calcium in keratinocytes
healing release (14).
than EGF in (ll),
stimulation
from
bone
The
basis
(13), for
0006-291x/90 615
of
$1.50
Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol.
166,
No.
2, 1990
the different have
BIOCHEMICAL
potencies
compared
of the EGF
AND
of the two
the effects
ligands
BIOPHYSICAL
RESEARCH
In this
is not known.
of TGF-alpha
and EGF
COMMUNICATIONS
report,
on degradation
we
and recycling
receptor.
MATERIALS
AND METHODS
Materials--TranS35-label (a mixture of [35S] methionine and cysteine) was from ICN, gamrn~-[~~P]-ATP from Amersham and [1251]-EGF was from NEN. EGF was from Collaborative Research or Amgen and recombinant TGF-alpha was from Bachem. Cell culture and Metabolic Labeling--NIH-3T3 cells expressing the human EGF receptor (15) were used throughout this work. Cells were cultured in DMEM containing 5% calf serum. Cells were [35S]-labeled for 16 hours and EGF receptor was immune precipitated from labeled cells using antibody against the human EGF receptor as previously described (16). Immune complex kinase assays and assay of [1251]-EGF binding were performed as described (16,17). As previously reported (18) we found TGFalpha to be about half as effective as EGF in competing for binding of [125I]EGF. Therefore, twice as much TGF-alpha as EGF was used in most experiments to ensure equal receptor occupancy. Ligand-induced EGF receptor internalization was determined by measuring the amount of bound [*251]-EGF (after cells were incubated with 50 rig/ml [ *251]-EGF for 30 minutes at 37OC) resistant to washing with 50 mM glycine,lOO mM NaCl, pH 3.0 (19). Analysis of EGF receptor tyrosine phosphorylation by immunoblotting was performed according Towbin et. al. (20) using antiserum against phosphotyrosine prepared as described by Ek and Heldin (21).
RESULTS We had the human products
EGF
found
receptor
with
of the receptor
(16).
the amino a minor
previously
terminus product
than
EGF
1).
When
labeled
for 12 hours,
the Mr=125,000
cells.
of the mature treated
sensitive, labeled
To abilities labeled
cells.
degradation In the immune from
of EGF
chased
or TGF-alpha.
in
a basis
for this
to generate
experiments normal
Both
were kinase
receptor
EGF-treated
of EGF only similar
degradation from or TGF-alpha in EGF
treated
in EGF
and
are heavily
but present
with
is much
assay, which
forms cells,
at
is more [32P]-
at about
lo-
treated cells. Again, labeling of the mature in assays from EGF and TGF-alpha treated cells.
and TGF-alpha
pulse-chase
receptor
is detected
receptor
truncated
precipitated
amounts
complex
and Mr=lOO,OOO
were
degradation
that TGF-alpha
immune
product EGF
expressing
was Mr=125,000
of these
saturating
Mr=170,000
to establish
products
formation
with
cells
of discrete
product
Here, we report were
treated
precipitates
attempt
and
degradation
and the major
receptors
levels in TGF-alpha receptor was similar
we performed EGF
cells
the Mr=125,000 in immune
fold lower M,=170,000
These
EGF
of NIH-3T3
led to the generation
in inducing
metabolically
TGF-alpha
incubation
of about Mr=lOO,OOO.
less effective
Levels
EGF
of the receptor
products
(Fig.
that
ligands
(Fig.
medium markedly 616
apparent
difference
in the
these receptor degradation products, Cells were metabolically
2).
containing stimulated
saturating turnover
concentrations of the EGF
of
Vol.
166, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL
ABCDEF
RESEARCH COMMUNICATIONS
170125
200-
9768-
01
02
u. Effects of EGF and TGF-alpha on generation of a M,=125,000 proteolytic degradation product of the EGF receptor. In A, B, and C cells were [35S]-labeled for 16 hours with in the presence of vehicle (A), 200 rig/ml EGF (B), or 400 rig/ml TGF-alpha (C). Lysates were then immune precipitated with antibody against the human EGF receptor as described in “Materials and Methods”. For D through F normally growing cells were incubated with vehicle (D), 400 rig/ml TGF-alpha (E), or 200 rig/ml EGF (F) for the in vitro kinase assay. Lysates were prepared and immune precipitated with antibody against the EGF receptor and precipitated receptor forms autophosphorylated with gamma-[32P]-ATP as described in “Materials and Methods”. Positions of molecular weight standards (x 103) are indicated. w. EGF and TGF-alpha -induced degradation of the EGF receptor. Cells were [J5S]-labeled for 16 hours for pulse-chase experiments as described in “Materials and Methods”. Labeling medium was removed and cells were lysed as zero time controls (A and F) or chased for 2 hours (B and G), 6 hours (C and H), 12 hours (D and I) or 24 hours (E, I, and K) in normal medium (K), &ma1 medium containing 200 n&ml EGF (B-E), or normal medium containing 400 rig/ml TGF-u/phi (G-J). -Cells were lysed and EGF receptor immune precipitated as described in “Materials and Methods”. Positions of the M,=l70,000 mature EGF receptor and Mr=125,000 receptor degradation product are shown. Results of a representative experiment are shown.
receptor, degree
although than
EGF
TGF-alpha
consistently
reduced
(compare
receptor
Particularly noticable two ligands). receptor to chase into the Mr=125,000 EGF. A relatively minor fraction M,=12.5,000 form when TGF-alpha Since of the EGF recycling cells
these
data
receptor
in cells exposed
were
incubated
with
minutes,
washed
extensively
binding
measured
at various
virtually
no recovery
whereas
TGF-alpha
was the
increased
alternate
saturating
bound,
unbound
of the mature into
3).
intracellular
routing
EGF
receptor
For these experiments,
of EGF
or TGF-ulphu
and recovery
for 30 of EGF
after the wash.
Cells exposed
to EGF
after removal
of EGF,
617
SO-70%
of
the
for up to 1 hour recovered
the
in the presence
of
ligand,
a greater
of chase with
we compared
(Fig.
concentrations
to remove
cells
to
tendency
product
pathways
to EGF of TGF-alpha
times
at 6 hours
degradation
on the ligand
of binding treated
levels
half-life
of the mature receptor chased was included in the chase.
suggested
dependent
receptor
of lost
binding
showed
activity
Vol. 166, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
P if? i x 2 f 8
ABCDE
03
FGH
MINUTES u. Recovery of [1251]-EGF binding following incubation of cells with saturating amounts of EGF or TGF-n&ha . Cells were incubated with 200 r&n1 EGF (squares) or 400 rig/ml TGF-alpha (triangles, x--x) for 30 minutes at which time samples were assayed for EGF binding or washed 4 times with normal medium and incubated at 37OC for various times prior to assay of [1251]-EGF binding. For data from samples represented by the open symbols, cells were treated with 50 ug/ml cycloheximide for 90 minutes prior to and throughout the experiment. For another group of samples, 10 mM methylamine was added 30 minutes prior to TGF-alpha addition and included throughout the remainder of the experiment (x--x). For binding assays, cells were incubated with 10 rig/ml [1251]-EGF for 4 hours at 4eC as described in “Materials and Methods”. u. EGF and TGF-alpha-induced tyrosine phosphorylation of the EGF Cultures of NIH-3T3 cells expressing the human EGF receptor were receptor. incubated for 30 minutes in normal growth medium containing vehicle (A, E), 100 @ml EGF (B,C,D), or 200 rig/ml TGF-alpha (F,G,H). Cells were then lysed in sample buffer (A,B,E,F) or washed 4 times with growth medium (37OC) and incubated for 15 minutes (C,G) or 45 minutes (D,H) prior to lysis. Proteins from lysates were separated on a 7.5% SDS gel and immunoblotting with antiphosphotyrosine antibody performed as described in “Materials and Methods”. The experiment was repeated 3 times with similar results. The position of the Mr=170,000 EGF receptor is indicated. during
this
period.
by greater
synthesis
intravesicular recovery
acid
pH
(which
inhibited
protein
of endosomes
with
and
lysosomes
(22,23),
by TGF-alpha
treated
or TGF-alpha
led to internalization
EGF
completely
inhibited
The initial 30 minute
cells.
of 70% to 80% of cell
receptors as judged by susceptibility of bound [1251]-EGF to removal by
wash
(19)
Since deficient
of cells
than
of binding
incubation
treatment
95%) had no effect on recovery of EGF binding by treated cells. However, methylamine, which perturbs the
TGF-alpha
surface
Cycloheximide
(not
EGF
EGF
shown).
does not increase
receptor
mutants
and
the rate of degradation such receptors
appear
of tyrosine to recycle
kinase in the
presence of EGF (24,25), we examined tyrosine phosphorylation of the EGF receptor by
following
immunoblotting
treatment with
of cells
with
EGF or TGF-alpha
anti-phosphotyrosine
618
antibodies,
(Fig. 4). treatment
As judged of
cells
Vol.
166, No. 2, 1990
for
30 minutes
BIOCHEMICAL
with
either
ligand
autophosphorylation
of the EGF
when
ligand
extracellular
phosphorylation In this 1047
occurred
experiment cpm
counting.
was
respectively Lanes
Despite
bands
receptor
metabolism, to EGF
[3H]-thymidine
to about in cells
from
lanes
excised
and
we
were
not
RESEARCH COMMUNICATIONS
specific the same extent. loss of
initially
exposed
quantitated
(not
to TGF-alpha. 1161 cpm
by liquid
to detect
and
scintillation
of these
ligands
any difference
by these cells as judged
incorporation
tyrosine
178, and 134 respective
on the effects
able
However,
receptor
A and F contained
371, 253,
differences
or TGF-alpha
tyrosine
by washing,
and H contained
the observed
response
receptor rapidly
when
C,D,G,
induced
removed
more
receptor
AND BIOPHYSICAL
cpm. on
in mitogenic
by soft agar growth
or
shown).
DISCUSSION These induce
results
indicate
for the first time that EGF and TGF-alpha
processing
of the EGF
receptor
through
altered
degradation
of the EGF
receptor
in TGF-alpha
rapid,
cycloheximide
TGF-alpha
insensitive
binding
surface
suggest
following
bound routing
membrane.
in
these
Although difference
treated
to a degradative
cells
recycle
prior
binding
to the cells initially
to recylcing
results
pathway
with
of receptor
in a more
little
both
ligands
degradative
approximately
greatly
relative
reduce abilities
intermediate
equivalent
It is possible
receptor. degradation
of
the
of the EGF
receptor
mechanisms
responsible
are not clear. be necessary mutant line,
receptors binding
pH range TGF-alpha receptor occur
that
receptor,
receptor
apparent
half-life,
a striking
to cause accumulation
of the EGF
for
receptor.
of a
Cells
appear
to inducing binding
kinase
as for the kinase
degradative
continuously
degradation
following deficient
This
EGF
receptor
and kinase
could Our
of EGF occurs
(24.25).
over
for more
lead to more
internalization,
619
of the
The
of the receptor
allowing
mutant.
of much
has been shown
to the EGF receptor vesicles.
slower
in the routing
of the receptor
in the presence
(6), perhaps
mature
than does EGF.
processing
activity
higher levels while each
M,=170,000
somewhat
results
pathway
differential
kinase
to recycle
to EGF
in endocytic tyrosine
in addition
induced
of TGF-alpha
of the mature
TGF-alpha this
tyrosine
EGF
compared
amounts
to a different
The for
direct
cells.
exposed to saturating amounts of EGF accumulate about 10 times of this M,=125,000 receptor form than cells exposed to TGF-u2phu., possess
and the following
Evidently,
internalization. EGF
The
binding
effeciently
the receptor
In contrast,
is seen in their
Mr=125,000
from
pathways.
of [ 1 251]-EGF
receptors
induced
dissociates
of the receptor
recycling
that
TGF-alpha
TGF-alpha
to the plasma
recovery
different
can
rapid
allowing
deficient
Along
this
a much narrower
rapid
data examining
to
dissociation inactivation
recycling
to
the rate of
of of
Vol. 166, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
dephosphorylation of tyrosine residues of the EGF receptor following exposure of cells to EGF versus TGF-alpha support this concept. Recycling could provide a mechanism whereby receptor signaling events which occur at the plasma membrane are amplified, perhaps explaining some of the results in which TGF-alpha functions as a superagonist relative to EGF.
Many of the responsesfor which TGF-alpha is a stronger
agonist than EGF such as induction of cell surface ruffling (26), induction of calcium release from bone cultures (13), and stimulation of arterial blood flow (27) probably involve processesat the plasma membrane and may not result in mitogenesis.
ACKNOWLEDGMENTS Thanks to Kathryn Malakom for technical assistance and Alan Saltiel and Antony Rosen for helpful suggestions. This work was supported by research grant CA37754 from the National Cancer Institute.
REFERENCES 1. Derynck, R. (1988) Cell 54, 593-595. 2. Gray, A., Dull, T.J., and Ullrich, A. (1983) Nature 303, 722-725. 3. Scott, J. Urdea, M., Quiroga, M., Sanchez-Pescador,R., Fong, N., Selby, M., Rutter, W.J., and Bell, G.I. (1983) Science 221, 236-240. 4. Derynck, R., Roberts, A.B., Winkler, M.E., Chen, E.Y., and Goeddel, D.V. (1984) Cell 38, 287-297. 5. Pike, L.J., Marquardt, H., Todaro, G.J., Gallis, B., Casnellie,J,E., Bomsten, P., and Krebs, E.G. (1982) J. Biol. Chem. 257, 14628-14631. 6. Massague,J. (1983) J. Biol. Chem. 258, 13614-13620. 7. Ran, W., Dean, M., Levine, R.A., Henkle, C., and Campisi,J. (1986) Proc. Natl. Sci. USA 83, 2228-2232. 8. Cutry, A.F., Kinniburgh, A.J., Twardzik, D.R., and Wenner, C.E. (1988) Biochem. Biophys. Res. Commun. 152, 216-222. 9. Schreiber, A.B., Winker, M.E., and Derynck, R. (1986) Science 232, 12501253. 10. Anzano, M.A.,Roberts, A.B., Smith, J.M., Spom, M.B., and DeLarco, J.E. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 6264-6268. 11. Schlutz, B.S., White, M., Mitchell, R., Brown, G., Lynch, J., Twardzik, D.R., and Todaro, G.J. (1987) Science 235, 350-352. 12. Ristimaki, A. (1989) Biochem. Biophys. Res. Commun. 160, 1100-1105. 13. Ibbotson, K.J., Harrod, J., Gowen, M., D’Souza, S., Smith, D.D., Winkler, M.E., Derynck, R., and Mundy, G.R. (1986) Proc. Acad. Sci. U.S.A. 83, 2228-2232. 14. Barrandon, Y., and Green, H. (1987) Cell 50, 1131-1137. 15. Velu, T.J., Beguinot, L., Vass, W.C., Willingham, M.C., Merlino, G.T., Pastan, I, and Lowy, D. (1987) Science 238, 1408-1410. 16. Decker, S.J. (1989) J. Biol. Chem. 264, 17641-17644(Oct. 25, 1989 issue). 17. Decker, S.J., and Harris, P. (1989) J. Biol. Chem. 264, 92049209. 18. Winkler, M.E., Bringman, T., and Marks, B.J. (1987) J. Biol. Chem. 261, 1383813843. 19. Ascoli, M. (1983) J. Biol. Chem. 260, 9613-9617. 20. Towbin, H., Staehilin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 4350-4354.
21. Ek, B., and Heldm, C. (1984) J. Biol. Chem. 259, 11145-11152. 620
Vol.
166, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
22. Maxfield, F.R. (1982) J. Cell Biol. 95, 676-684. 23. King, A.C., Hemaez-Davis, N., and Cuatrecasas,P. (1981) Proc. Natl. Acad. Sci U.S.A. 78, 717-721. 24. Glenney, J.R., Jr., Chen, W.S., Lazar, C.S., Walton, G.M., Zokas, L.M., Rosenfeld,M.G., and Gill, G.N. (1988) Cell 52, 675-684. 25. Honegger, A.M., Dull, T.J., Felder, S., Obberghen,E.V., Bellot, F., Szapary, D., Schmidt, A., Ullich, A., and Schlessinger,J. (1987) Cell 51, 199-209. 26. Myrdal, S.E., Twardzik, D.R., and Auersperg, N. (1985) J. Cell Biol. 102, 12301234. 27. Gan, B.S., Hollenberg, M. D., MacCannell, K.C. Lederis, K., Winkler, M.E., and Derynck, R. (1987) J. Pharm. Exp. Ther. 242, 331-337.
621